Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Palantir stock: Wall Street analyst issues a massive warning

Published 08/02/2024, 04:01 AM
Updated 08/02/2024, 04:29 AM
©  Reuters
PLTR
-

Analysts at Monness, Crespi, and Hardt issued a massive warning to investors regarding Palantir stock ahead of the software maker’s earnings report next week.

Specifically, analysts warned the company's shares are trading at “an absurd valuation” fueled by a “19-month genAI propaganda cycle.”

“Based on our estimates, Palantir garners the richest valuation in our enterprise software group based on EV/revenue, while also claiming the top spot in our coverage universe at large,” they noted.

“Given the exorbitant number of shares outstanding, we believe it will take several years for Palantir to grow into its current valuation.”

While Monness analysts see Palantir Technologies Inc (NYSE:PLTR) as well-positioned to benefit from the AI trend and capitalize on volatile geopolitics in the long run, they consider the current valuation to be extreme.

The brokerage firm points out several factors driving its bearish thesis, such as the pressured software sector, inconsistent revenue recognition from government-related contracts, and spotty execution. Notably, analysts believe “the darkest days of this economic quagmire are ahead of us.”

With respect to the upcoming earnings report, Monnes expects Palantir to meet their 2Q24 revenue estimate of $665.9 million and EPS forecast of $0.09, slightly above consensus estimates.

Year-over-year revenue growth is expected to accelerate to 25% in 2Q24 from 21% in 1Q24 and 13% in 2Q23.

They forecast an operating profit of $240.4 million, representing a 36.1% margin, up from 35.7% in 1Q24 and 25.3% in 2Q23.

Government revenue is projected at $351.8 million and commercial sales at $314.1 million, with government segment growth accelerating to 17% in 2Q24 and commercial segment growth to 36%.

“Palantir has experienced strong trends within its U.S. commercial business in recent quarters; however, this market is susceptible to the vicissitudes of the economy,” analysts added.

Palantir stock rose more than 51% in 2024, outperforming the broader market.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.